SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 62 filers reported holding SPERO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,598 | -83.2% | 17,023 | -79.9% | 0.00% | – |
| Q2 2023 | $122,576 | +163.3% | 84,535 | +163.3% | 0.00% | – |
| Q1 2023 | $46,545 | -32.4% | 32,100 | -19.3% | 0.00% | – |
| Q4 2022 | $68,845 | -78.8% | 39,795 | -90.9% | 0.00% | -100.0% |
| Q2 2022 | $324,000 | -52.8% | 437,280 | +454.2% | 0.00% | -50.0% |
| Q1 2022 | $686,000 | -18.4% | 78,908 | +81.9% | 0.00% | 0.0% |
| Q4 2020 | $841,000 | +120.7% | 43,373 | +54.1% | 0.00% | 0.0% |
| Q2 2020 | $381,000 | +110.5% | 28,150 | +49.5% | 0.00% | +100.0% |
| Q4 2019 | $181,000 | +7.1% | 18,828 | -31.4% | 0.00% | 0.0% |
| Q4 2018 | $169,000 | – | 27,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,932,209 | $76,246,000 | 15.85% |
| Atlas Venture Associates XI, LLC | 1,376,968 | $26,700,000 | 4.23% |
| Atlas Venture Associates IX, LLC | 1,376,968 | $26,700,000 | 4.23% |
| BVF INC/IL | 2,243,278 | $43,497,000 | 1.71% |
| AWM Investment Company, Inc. | 372,755 | $7,228,000 | 0.92% |
| Alphabet Inc. | 889,979 | $17,257,000 | 0.83% |
| Rock Springs Capital Management LP | 1,235,000 | $23,947,000 | 0.51% |
| Novo Holdings A/S | 576,702 | $11,182,000 | 0.48% |
| Artal Group S.A. | 500,000 | $9,695,000 | 0.21% |
| Granahan Investment Management | 420,320 | $8,150,000 | 0.18% |